RCCD1-AS1

Across TCGA pan-cancer cohorts, RCCD1-AS1 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated RCCD1-AS1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RCCD1-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RCCD1-AS1 expression acts as an unfavorable survival marker, although some lineages such as CESC and OV show a favorable association.

KIRC, ACC, and LIHC are the cancer types where RCCD1-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.463	0.715	<.001	156	view →
ACC	OS	Median	All	0.424	0.830	<.001	91	view →
LIHC	DFS	Quartile	All	0.292	0.521	<.001	38	view →
COAD	OS	Tertile	III,IV	0.593	0.894	.001	35	view →
CESC	OS	Median	All	0.863	0.731	.004	32	view →
LGG	DFS	Median	All	0.663	0.796	<.001	29	view →
PRAD	DFS	Median	All	0.822	0.937	<.001	28	view →
ESCA	DFS	Tertile	III,IV	0.211	0.487	<.001	24	view →
OV	DFS	Median	IV	0.406	0.222	.009	18	view →
KICH	DFS	Quartile	II,III,IV	0.538	1.000	.027	12	view →
UVM	OS	Median	III,IV	0.296	1.000	.005	12	view →
LAML	DFS	Median	All	0.496	0.643	.030	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

RCCD1-AS1–KIRC (OS)

Open the KIRC breakdown →